Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs
- PMID: 16413079
- DOI: 10.1016/j.jbiotec.2005.12.003
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs
Abstract
RNA interference (RNAi) offers great potential not only for in vitro target validation, but also as a novel therapeutic strategy based on the highly specific and efficient silencing of a target gene, e.g. in tumor therapy. Since it relies on small interfering RNAs (siRNAs), which are the mediators of RNAi-induced specific mRNA degradation, a major issue is the delivery of therapeutically active siRNAs into the target tissue/target cells in vivo. For safety reasons, strategies based on (viral) vector delivery may be of only limited clinical use. The more desirable approach is to directly apply catalytically active siRNAs. This review highlights the recent knowledge on the guidelines for the selection of siRNAs which show high activity in the absence of non-specific siRNA effects. It then focuses on approaches to directly use siRNA molecules in vivo and gives a comprehensive overview of in vivo studies based on the direct application of siRNAs to induce RNAi. One promising approach is the in vivo siRNA delivery through complexation of chemically unmodified siRNAs with polyethylenimine (PEI). The anti-tumoral effects of PEI/siRNA-based targeting of tumor-relevant genes in vivo are described.
Similar articles
-
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.Eur J Pharm Biopharm. 2011 Apr;77(3):438-49. doi: 10.1016/j.ejpb.2010.11.007. Epub 2010 Nov 18. Eur J Pharm Biopharm. 2011. PMID: 21093588 Review.
-
Hydrodynamic delivery protocols.Methods Mol Biol. 2010;623:189-95. doi: 10.1007/978-1-60761-588-0_12. Methods Mol Biol. 2010. PMID: 20217552
-
Nonviral in vivo delivery of therapeutic small interfering RNAs.Curr Opin Mol Ther. 2007 Aug;9(4):345-52. Curr Opin Mol Ther. 2007. PMID: 17694447 Review.
-
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.Gene Ther. 2005 Mar;12(5):461-6. doi: 10.1038/sj.gt.3302425. Gene Ther. 2005. PMID: 15616603
-
Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass.Gene Ther. 2008 Aug;15(15):1126-30. doi: 10.1038/gt.2008.24. Epub 2008 Mar 6. Gene Ther. 2008. PMID: 18323791
Cited by
-
Toward personalized cancer nanomedicine - past, present, and future.Integr Biol (Camb). 2013 Jan;5(1):48-65. doi: 10.1039/c2ib20104f. Integr Biol (Camb). 2013. PMID: 22858688 Free PMC article.
-
Flotillin-2 is an acrosome-related protein involved in mouse spermiogenesis.J Biomed Res. 2012 Jul;26(4):278-87. doi: 10.7555/JBR.26.20120030. Epub 2012 Jul 2. J Biomed Res. 2012. PMID: 23554761 Free PMC article.
-
RNA interference with special reference to combating viruses of crustacea.Indian J Virol. 2012 Sep;23(2):226-43. doi: 10.1007/s13337-012-0084-1. Epub 2012 Aug 14. Indian J Virol. 2012. PMID: 23997446 Free PMC article.
-
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6 Expression.J Biol Chem. 2016 Apr 29;291(18):9540-53. doi: 10.1074/jbc.M115.692368. Epub 2016 Feb 9. J Biol Chem. 2016. PMID: 26861876 Free PMC article.
-
C. elegans RNAi space experiment (CERISE) in Japanese Experiment Module KIBO.Biol Sci Space. 2009 Oct 1;23(4):183-187. doi: 10.2187/bss.23.183. Biol Sci Space. 2009. PMID: 20729992 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources